INOVIO PHARMACEUTICALS, INC.·4

May 21, 4:11 PM ET

Weiner David B. 4

4 · INOVIO PHARMACEUTICALS, INC. · Filed May 21, 2026

Research Summary

AI-generated summary of this filing

Updated

INO Director David B. Weiner Receives Equity Awards

What Happened

  • Director David B. Weiner was granted a total of 76,000 derivative awards on May 20, 2026: 41,800 option-type awards and 34,200 restricted stock units (RSUs). Both grants are reported at $0.00 per share in the Form 4 (derivative awards) and were issued under the company's 2023 Omnibus Incentive Plan as part of the non-employee director compensation policy. The options and RSUs each vest 100% on May 20, 2027.

Key Details

  • Transaction date: 2026-05-20; Filing date: 2026-05-21 (filed next day).
  • Awards: 41,800 derivatives (options) @ $0.00; 34,200 RSUs @ $0.00; total = 76,000 awards.
  • Vesting: Both the options and the RSUs vest 100% on May 20, 2027 (Footnotes F2, F3).
  • Plan/Policy: Granted under the 2023 Omnibus Incentive Plan pursuant to the issuer’s non-employee director compensation policy (Footnote F1).
  • Shares owned after transaction: Not specified in the Form 4 filing.
  • Timeliness: Filing appears timely (reported date 5/20/2026; filed 5/21/2026).

Context

  • These are compensation grants (not open-market purchases or sales). Options are derivative rights that, upon vesting and any required exercise, may convert into shares; RSUs represent a contingent right to receive one share each at vesting. Such awards are common for non-employee directors and reflect standard compensation rather than an express buy/sell signal.

Insider Transaction Report

Form 4
Period: 2026-05-20
Transactions
  • Award

    Common Stock Options

    [F1][F2]
    2026-05-20+41,80041,800 total
    Exercise: $1.23Exp: 2036-05-20Common Stock (41,800 underlying)
  • Award

    Restricted Stock Unit

    [F3][F1]
    2026-05-20+34,20034,200 total
    Common Stock (34,200 underlying)
Footnotes (3)
  • [F1]This grant was made under the 2023 Omnibus Incentive Plan pursuant to the issuer's non-employee director compensation policy.
  • [F2]Options to vest 100% on May 20, 2027.
  • [F3]Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 20, 2027.
Signature
/s/ David B. Weiner|2026-05-21

Documents

1 file
  • 4
    wk-form4_1779394282.xmlPrimary

    FORM 4